Drug Profile
Research programme: cancer therapeutics - GENova
Alternative Names: Prostaganin; Tetanolic acidLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GENova Biotherapeutics
- Class Lipids; Oleic acids; Peptides
- Mechanism of Action Cell membrane structure modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Breast cancer; Prostate cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Breast-cancer in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Prostate-cancer in USA (Parenteral)
- 14 Sep 2009 Compounds in research programme are available for licensing in worldwide as of 14 Sep 2009. http://www.genovabio.com